記住我
Secondary progressive multiple sclerosis
Active disease
Siponimod
S1P modulator
Age subgroups
Adverse events
Abbreviations3mCDP3-month confirmed disability progression
6mCDP6-month confirmed disability progression
CDPConfirmed disability progression
DMTDisease-modifying therapy
EDSSExpanded Disability Status Scale
RRMSRelapsing-remitting multiple sclerosis
S1PSphingosine 1-phosphate
SPMSSecondary progressive multiple sclerosis
© 2023 The Authors. Published by Elsevier B.V.
留言 (0)